Class II transactivator (CIITA) deficiency in tumor cells: Complicated mechanisms or not? [5] (multiple letters)

American Journal of Pathology

Volumn 163, Issue 1, 2003, Pages 373-376

  Van den Elsen, Peter J ^a   Van der Stoep, Nienke ^a   Yazawa, Takuya ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; DNA; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; CANCER CELL CULTURE; DNA METHYLATION; ERYTHROLEUKEMIA CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LETTER; LUNG CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIGENE FAMILY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL CELL CARCINOMA; SOUTHERN BLOTTING; TRANSACTIVATION; TUMOR CELL;

EID: 0038305942     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63664-4     Document Type: Letter

References (37)

1. P Möller GJ Hammerling The role of surface HLA-A, B, C molecules in tumour immunity Cancer Surv 13 1992 101 127
2. F Garrido F Ruiz-Cabello T Cabrera JJ Perez-Villar M Lopez-Botet M Duggan-Keen PL Stern Implications for immunosurveillance of altered HLA class I phenotypes in human tumours Immunol Today 18 1997 89 95
3. I Algarra T Cabrera F Garrido The HLA crossroad in tumor immunology Hum Immunol 61 2000 65 73
4. AC Morris JL Riley WH Fleming JM Boss MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression Am J Reprod Immunol 40 1998 385 394
5. SP Murphy TB Tomasi Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression Mol Reprod Dev 51 1998 1 12
6. N Van der Stoep P Biesta E Quinten PJ Van den Elsen Lack of IFN-γ-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines Int J Cancer 97 2002 501 507
7. T Yazawa H Kamma M Fujiwara M Matsui H Horiguchi H Satoh M Fujimoto K Yokoyama T Ogata Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer J Pathol 187 1999 191 199
8. Y Lu ME Tschickardt BJ Schmidt G Blanck IFN-γ inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-γ inducibility of the HLA class II genes Immunol Cell Biol 75 1997 325 332
9. PJ Van den Elsen N Van der Stoep HE Vietor L Wilson M Van Zutphen SJ Gobin Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-γ-inducible promoter (PIV) of CIITA Hum Immunol 61 2000 850 862
10. T Yazawa T Ito H Kamma T Suzuki K Okudela H Hayashi H Horiguchi T Ogata H Mitsui M Ikeda H Kitamura Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma Am J Pathol 161 2002 291 300
11. A Liu M Takahashi K Toba Z Zheng S Hashimoto K Nikkuni T Furukawa T Koike Y Aizawa Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells Hematol Oncol 17 1999 149 160
12. A Peijnenburg SJ Gobin MC van Eggermond BC Godthelp N van Graafeiland PJ van den Elsen Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression J Immunol 159 1997 2720 2727
13. C Benoist D Mathis Regulation of major histocompatibility complex class-II genes: x, y, and other letters of the alphabet Annu Rev Immunol 8 1990 681 715
14. LH Glimcher CJ Kara Sequences and factors: a guide to MHC class-II transcription Annu Rev Immunol 10 1992 13 49
15. SJ Gobin A Peijnenburg V Keijsers PJ van den Elsen Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA Immunity 6 1997 601 611
16. A Muhlethaler-Mottet LA Otten V Steimle B Mach Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA EMBO J 16 1997 2851 2860
17. JF Piskurich Y Wang MW Linhoff LC White JP Ting Identification of distince regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β regulated expression of the class II transactivator gene J Immunol 160 1998 233 240
18. Y Dong WM Rohn EN Benveniste IFN-γ regulation of the type IV class II transactivator promoter in astrocytes J Immunol 162 1999 4731 4739
19. A Muhlethaler-Mottet W Di Berardino LA Otten B Mach Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1 Immunity 8 1998 157 166
20. JF Piskurich MW Linhoff Y Wang JP-Y Ting Two distinct γ-interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by Stat1, interferon regulatory factor 1, and transforming growth factor β Mol Cell Biol 19 1999 431 440
21. W Rohn LP Tang Y Dong EN Benveniste IL-1 β inhibits IFN-γ-induced class II MHC expression by suppressing transcription of the class II transactivator gene J Immunol 162 1999 886 896
22. AC Morris WE Spangler JM Boss Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control J Immunol 164 2000 4143 4149
23. SP Murphy R Holtz N Lewandowski TB Tomasi H Fuji DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells J Immunol 169 2002 3085 3093
24. T Yazawa T Ito H Kamma T Suzuki K Okudela H Hayashi H Horiguchi T Ogata H Mitsui M Ikeda H Kitamura Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma Am J Pathol 161 2002 291 300
25. S Ostrand-Rosenberg A Thakur V Clements Rejection of mouse sarcoma cells after transfection of MHC class II genes J Immunol 144 1990 4068 4071
26. H Kamma K Fujii T Ogata Lymphocytic infiltration in juvenile thyroid carcinoma Cancer 62 1988 1988 1993
27. Yazawa H Kamma T Ogata Frequent expression of HLA-DR antigen in medullary carcinoma of the breast: a possible reason for its prominent lymphocytic infiltration and favorable prognosis Appl Immunohistochem 1 1993 289 296
28. T Yazawa H Kamma M Fujiwara M Matsui H Horiguchi H Satoh M Fujimoto K Yokoyama T Ogata Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer J Pathol 187 1999 191 199
29. JF Piskurich MW Linhoff Y Wang JP-Y Ting Two distinct γ-interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by Stat1, interferon regulatory factor 1, and transforming growth factor β Mol Cell Biol 19 1999 431 440
30. N Van der Stoep P Biesta E Quinten PJ Van den Elsen Lack of IFN-γ-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines Int J Cancer 97 2002 501 507
31. PJ Van den Elsen N Van der Stoep HE Vietor L Wilson M Van Zutphen SJ Gobin Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-γ inducible promoter (PIV) of CIITA Hum Immunol 61 2000 850 862
32. WD Travis TV Colby B Corrin Y Shimosato E Brambilla World Health Organization: Histological Typing of Lung and Pleural Tumours ed 3. 1999 Springer-Verlag Heidelberg 1 156
33. S Hougaard P Norgaard N Abrahamsen HL Moses M Spang-Thomsen H Skovgaard Poulsen Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines Br J Cancer 79 1999 1005 1011
34. H Osada Y Tatematsu A Masuda T Saito M Sugiyama K Yanagisawa T Takahashi Heterogeneous transforming factor (TGF)-β unresponsiveness and loss of TGF-β receptor type II expression caused by histone deacetylation in lung cancer cell lines Cancer Res 61 2001 8331 8339
35. JF Piskurich Y Wang MW Linhoff LC White JP Ting Identification of distance regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β regulated expression of the class II transactivator gene J Immunol 160 1998 233 240
36. M Schwab H Shimada V Joshi GM Brodeur Neuroblastic tumours of adrenal gland and sympathetic nervous system P Kleihues WK Cabenee Pathology and Genetics of Tumours of the Nervous System 2000 International Agency for Research on Cancer Lyon 116 153
37. BK Martin KC Chin JC Olsen CA Skinner A Dey K Ozato JP Ting Induction of MHC class I expression by the MHC class II transactivator CIITA Immunity 6 1997 591 600